Overview of Acinetobacter baumannii, as the most common Gram-negative bacillus in the genus Acinetobacter, is widespread in nature and usually causes bacteremia, pneumonia, meningitis, peritonitis, endocarditis, and urinary tract and skin infections. The bacterium is usually found in hospital infections, with a greater chance of infection in the elderly, is very resistant to drugs, and is very dangerous when infected, causing respiratory tract inflammation, central nervous system infections, and urinary tract infections. Symptoms of intracranial infection with Acinetobacter baumannii Intracranial infection is one of the more serious diseases of the central nervous system, and if infected with Acinetobacter baumannii, it is very difficult to treat. Some patients ask, “What are the symptoms of intracranial infection with Acinetobacter baumannii? Patients may experience headache, vomiting, generalized fever, and meningitis symptoms such as cervical tonicity. These symptoms are usually easily detectable by patients. Can intracranial infection with Acinetobacter baumannii be saved and what is the mortality rate? Intracranial infection with Acinetobacter baumannii has a high mortality rate. Acinetobacter baumannii, as a drug-resistant bacterium, is inherently difficult to treat. When the infection is intracranial, the presence of the blood-brain barrier undoubtedly makes it more difficult to treat. In addition, the mortality rate of this infection is also higher, and the general anti-infective treatment is less effective after clinical feedback. Is there no rule of law for intracranial infection with A. baumannii? In fact, no. Nowadays, medicine is so advanced that as long as the correct treatment is found, the possibility of patients regaining their health is still great. At present, there is a set of advanced and effective cerebrospinal fluid specialty technology, effective treatment for various intracranial infections, especially for intracranial infections caused by Acinetobacter baumannii, can achieve ideal results, patients are recommended to go to the regular hospital cerebrospinal fluid department to receive scientific treatment.